🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 4 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/09/2000 | 65,90 | 66,91 | 65,90 | 66,02 | -1,01% | 1,54% | 3.800.572 |
| 31/08/2000 | 67,75 | 68,82 | 66,67 | 66,69 | -1,74% | 3,17% | 5.503.153 |
| 30/08/2000 | 67,33 | 68,17 | 66,79 | 67,87 | -0,09% | 2,04% | 3.163.598 |
| 29/08/2000 | 69,18 | 69,18 | 67,45 | 67,93 | -1,77% | 2,50% | 3.116.333 |
| 28/08/2000 | 69,54 | 70,31 | 69,06 | 69,15 | -0,64% | 1,80% | 2.999.376 |
| 25/08/2000 | 69,18 | 69,78 | 68,82 | 69,60 | +0,60% | 1,38% | 2.587.093 |
| 24/08/2000 | 68,82 | 69,78 | 68,05 | 69,18 | +0,35% | 2,51% | 2.820.692 |
| 23/08/2000 | 69,18 | 69,95 | 68,52 | 68,94 | -0,34% | 2,07% | 3.268.817 |
| 22/08/2000 | 68,70 | 69,66 | 68,46 | 69,18 | +0,87% | 1,74% | 2.890.489 |
| 21/08/2000 | 68,11 | 69,54 | 68,11 | 68,58 | -0,17% | 2,10% | 2.453.368 |
| 18/08/2000 | 69,84 | 69,95 | 68,23 | 68,70 | -2,62% | 2,48% | 4.252.365 |
| 17/08/2000 | 70,13 | 70,97 | 69,78 | 70,55 | +0,42% | 1,70% | 2.772.694 |
| 16/08/2000 | 69,95 | 70,91 | 69,90 | 70,25 | +0,51% | 1,45% | 2.335.363 |
| 15/08/2000 | 69,90 | 70,25 | 69,18 | 69,90 | +0,56% | 1,54% | 3.133.939 |
| 14/08/2000 | 69,06 | 69,78 | 68,94 | 69,51 | +0,60% | 1,21% | 2.456.302 |
| 11/08/2000 | 68,05 | 69,78 | 68,05 | 69,09 | +1,31% | 2,54% | 2.987.324 |
| 10/08/2000 | 67,69 | 68,76 | 67,21 | 68,20 | +1,28% | 2,29% | 4.499.274 |
| 09/08/2000 | 68,11 | 70,01 | 66,79 | 67,33 | -2,48% | 4,73% | 6.504.726 |
| 08/08/2000 | 69,36 | 70,07 | 68,40 | 69,05 | -0,92% | 2,41% | 4.243.771 |
| 07/08/2000 | 70,37 | 70,37 | 69,42 | 69,69 | -1,06% | 1,36% | 4.050.625 |
| 04/08/2000 | 70,73 | 70,97 | 69,72 | 70,43 | -1,87% | 1,77% | 3.296.170 |
| 03/08/2000 | 71,68 | 71,98 | 71,09 | 71,77 | +0,29% | 1,25% | 4.532.914 |
| 02/08/2000 | 70,85 | 71,80 | 70,25 | 71,56 | +1,22% | 2,19% | 4.731.091 |
| 01/08/2000 | 67,87 | 70,85 | 67,87 | 70,70 | +3,40% | 4,39% | 4.829.394 |
| 31/07/2000 | 68,76 | 69,00 | 67,09 | 68,37 | -1,55% | 2,78% | 3.916.271 |
| 28/07/2000 | 69,66 | 69,78 | 69,12 | 69,45 | +0,60% | 0,94% | 4.358.527 |
| 27/07/2000 | 67,51 | 69,42 | 66,79 | 69,03 | +3,35% | 3,89% | 4.222.392 |
| 26/07/2000 | 68,11 | 68,40 | 66,56 | 66,79 | -1,28% | 2,71% | 6.114.032 |
| 25/07/2000 | 66,26 | 68,58 | 65,72 | 67,66 | +1,93% | 4,32% | 11.350.783 |
| 24/07/2000 | 63,69 | 66,91 | 63,45 | 66,38 | +9,12% | 5,43% | 14.382.962 |